
HCA Healthcare (HCA) Stock Forecast & Price Target
HCA Healthcare (HCA) Analyst Ratings
Bulls say
HCA Healthcare is operating in an industry that is highly regulated, and there may be risks associated with Medicare and Medicaid. However, despite these risks, the company has a strong market position with a large network of hospitals and outpatient facilities, and is well-positioned for future growth. Management continues to focus on efficient operations and has a strong track record of generating solid cash flow and shareholder returns. The company's initial guidance for 2026 was solid with potential for additional upside from pending SDP approvals and a robust pipeline for outpatient opportunities. Overall, the positive financial outlook and strong fundamentals make HCA Healthcare a good investment opportunity.
Bears say
HCA Healthcare is facing significant headwinds in 2026, including a decline in exchange market volumes and a potential decline in utilization of care and shift toward ER usage. Additionally, the company's resiliency program, which aims to generate $400 million in savings, may not be enough to offset these challenges. Despite strong 4Q results, the company's outlook for 2026 includes a decrease in adjusted EBITDA due to these headwinds, and the stock's long-term average multiple of 9x may be difficult to maintain in the face of these challenges.
This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.
HCA Healthcare (HCA) Analyst Forecast & Price Prediction
Start investing in HCA Healthcare (HCA)
Order type
Buy in
Order amount
Est. shares
0 shares